David J. Marguglio, Senior VP of Business Development at Adamis Pharmaceuticals Corp (ADMP), sold 100 shares at $5.01 ($501) on 2015-04-17, disclosed to the SEC on 2015-04-20.
Scheduled sale ($501) by Senior VP of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADMP | SELL | 2020-11-24 | $14K | — | Filing → |
| ADMP | SELL | 2020-11-20 | $3K | — | Filing → |
| ADMP | SELL | 2020-10-01 | $16K | — | Filing → |